A New Jersey appeals panel has handed Merck & Co. a victory in the mass litigation over its painkiller Vioxx by barring 98 English and Welsh users of the drug from suing in the state’s courts.
The plaintiffs wanted to take advantage of New Jersey’s plaintiff-friendly laws and fee-switching rules that do not exist in the United Kingdom, the other possible forum.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]